Analysis reveals miR-206 impacts radiosensitivity and SIRT1 activity in breast cancer cells, suggesting new treatment approaches.
Background MicroRNAs (miRNAs) are a group of small non-coding RNAs that substantially participate in regulating gene expression. Their participation in cancer development encompasses various critical pathways, spanning from cell transformation to the progression of tumor cells, metastasis, and even resistance to treatment. This study aimed to assess the impact of miR-206 on radiosensitivity in breast cancer (BC) cells, SIRT1 activity, and p53 acetylation.
No takes yet. Share an insight, caveat, or question.
Seiri et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: